Trial Profile
A Phase II, Multicentre, Randomised, Double-blind, Parallel Groups, Placebo Controlled Clinical Study of Efficacy and Safety of Dysport for Migraine Prophylaxis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Apr 2020
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Migraine
- Focus Therapeutic Use
- Sponsors Ipsen
- 12 Sep 2007 Status changed from in progress to completed.
- 05 Nov 2006 New trial record.